Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 95

    1.

    Establishing humanized mice using stem cells: maximizing the potential.

    Bernard D, Peakman M, Hayday AC.

    Clin Exp Immunol. 2008 Jun;152(3):406-14. Epub 2008 Apr 24. Review.PMID: 18435804 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice.

    Rice AM, Wood JA, Milross CG, Collins CJ, McCarthy NF, Vowels MR.

    Transplantation. 2000 Mar 15;69(5):927-35.PMID: 10755552 [PubMed - indexed for MEDLINE]Related articles

    3.

    Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.

    Hogan CJ, Shpall EJ, McNiece I, Keller G.

    Biol Blood Marrow Transplant. 1997 Nov;3(5):236-46.PMID: 9450918 [PubMed - indexed for MEDLINE]Related articles

    4.

    Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice.

    Chen BP, Galy A, Kyoizumi S, Namikawa R, Scarborough J, Webb S, Ford B, Cen DZ, Chen SC.

    Blood. 1994 Oct 15;84(8):2497-505.PMID: 7522631 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Cell separation improves the sensitivity of detecting rare human normal and leukemic hematopoietic cells in vivo in NOD/SCID mice.

    Holyoake TL, Horrocks C, Thomas T, Eaves CJ, Eaves AC.

    Cytotherapy. 2000;2(6):411-21.PMID: 12044221 [PubMed - indexed for MEDLINE]Related articles

    6.

    Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation.

    Lan P, Tonomura N, Shimizu A, Wang S, Yang YG.

    Blood. 2006 Jul 15;108(2):487-92. Epub 2006 Jan 12.PMID: 16410443 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Engraftment potential of human fetal hematopoietic cells in NOD/SCID mice is not restricted to mitotically quiescent cells.

    Wilpshaar J, Bhatia M, Kanhai HH, Breese R, Heilman DK, Johnson CS, Falkenburg JH, Srour EF.

    Blood. 2002 Jul 1;100(1):120-7.PMID: 12070016 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7.

    Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M.

    Blood. 2000 May 1;95(9):2813-20.PMID: 10779426 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Human-mouse xenografts in stem cell research.

    Wermann K, Fruehauf S, Haas R, Zeller WJ.

    J Hematother. 1996 Aug;5(4):379-90. Review.PMID: 8877713 [PubMed - indexed for MEDLINE]Related articles

    12.

    Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo.

    DiGiusto DL, Lee R, Moon J, Moss K, O'Toole T, Voytovich A, Webster D, Mule JJ.

    Blood. 1996 Feb 15;87(4):1261-71.PMID: 8608214 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Coculture and transplant of purified CD34(+)Lin(-) and CD34(-)Lin(-) cells reveals functional interaction between repopulating hematopoietic stem cells.

    Hess DA, Karanu FN, Levac K, Gallacher L, Bhatia M.

    Leukemia. 2003 Aug;17(8):1613-25.PMID: 12886251 [PubMed - indexed for MEDLINE]Related articles

    14.

    Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.

    Huang GP, Pan ZJ, Jia BB, Zheng Q, Xie CG, Gu JH, McNiece IK, Wang JF.

    Cell Transplant. 2007;16(6):579-85.PMID: 17912949 [PubMed - indexed for MEDLINE]Related articles

    15.

    Characterization of purified and ex vivo manipulated human hematopoietic progenitor and stem cells in xenograft recipients.

    Bock TA, Ziegler BL, Bühring HJ, Scheding S, Brugger W, Kanz L.

    Ann N Y Acad Sci. 1999 Apr 30;872:200-7; discussion 207-10. Review.PMID: 10372123 [PubMed - indexed for MEDLINE]Related articles

    16.

    CD34+, kit+, rhodamine123(low) phenotype identifies a marrow cell population highly enriched for human hematopoietic stem cells.

    Ratajczak MZ, Pletcher CH, Marlicz W, Machalinski B, Moore J, Wasik M, Ratajczak J, Gewirtz AM.

    Leukemia. 1998 Jun;12(6):942-50.PMID: 9639424 [PubMed - indexed for MEDLINE]Related articles

    17.

    Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.

    Yoshino H, Ueda T, Kawahata M, Kobayashi K, Ebihara Y, Manabe A, Tanaka R, Ito M, Asano S, Nakahata T, Tsuji K.

    Bone Marrow Transplant. 2000 Dec;26(11):1211-6.PMID: 11149733 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    CD34+Thy-1+Lin- stem cells from mobilized peripheral blood.

    Murray LJ, Tsukamoto A, Hoffman R.

    Leuk Lymphoma. 1996 Jun;22(1-2):37-42, follow. 186, color plate I. Review.PMID: 8724526 [PubMed - indexed for MEDLINE]Related articles

    19.

    Humanized mice for the study of type 1 diabetes and beta cell function.

    King M, Pearson T, Rossini AA, Shultz LD, Greiner DL.

    Ann N Y Acad Sci. 2008 Dec;1150:46-53. Review.PMID: 19120266 [PubMed - indexed for MEDLINE]Related articles

    20.

    Ex vivo expansion and engraftment potential of cord blood-derived CD34+ cells in NOD/SCID mice.

    Fibbe WE, Noort WA, Schipper F, Willemze R.

    Ann N Y Acad Sci. 2001 Jun;938:9-17. Review.PMID: 11458530 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data